Logo image of AB.PA

AB SCIENCE SA (AB.PA) Stock Price, Quote, News and Overview

EPA:AB - Euronext Paris - Matif - FR0010557264 - Common Stock - Currency: EUR

1.154  0 (-0.35%)

AB.PA Quote, Performance and Key Statistics

AB SCIENCE SA

EPA:AB (6/18/2025, 10:00:20 AM)

1.154

0 (-0.35%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High2.34
52 Week Low0.77
Market Cap68.51M
Shares59.37M
Float38.98M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)09-29 2025-09-29
IPO04-21 2010-04-21


AB.PA short term performance overview.The bars show the price performance of AB.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20

AB.PA long term performance overview.The bars show the price performance of AB.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of AB.PA is 1.154 EUR. In the past month the price decreased by -17.52%. In the past year, price decreased by -2.2%.

AB SCIENCE SA / AB Daily stock chart

AB.PA Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
1LLY.MI ELI LILLY & CO 58.11 654.79B
LLY.DE ELI LILLY & CO 57.62 649.30B
ZEG.DE ASTRAZENECA PLC 16.58 388.64B
1JNJ.MI JOHNSON & JOHNSON 15.66 327.42B
JNJ.DE JOHNSON & JOHNSON 15.15 316.78B
NOV.DE NOVO NORDISK A/S-B 20.6 288.29B
RHO.DE ROCHE HOLDING AG-BR 14.86 240.35B
1SAN.MI SANOFI 11.27 210.93B
SNW.DE SANOFI 11.04 206.55B
SAN.PA SANOFI 10.77 201.53B
NOT.DE NOVARTIS AG-REG 14.21 201.30B
1MRKX.MI MERCK & CO. INC. 10.37 175.27B

About AB.PA

Company Profile

AB logo image AB Science SA operates as a pharmaceutical company, which engages in the research, development, and marketing of synthetic therapeutic molecules for pathologies with high medical need, in diseases of the central nervous system, cancers, and inflammatory diseases. The company is headquartered in Paris, Ile-De-France and currently employs 45 full-time employees. The company went IPO on 2010-04-21. The company is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine. The main focus of the Company is the development of tyrosine kinase inhibitors, for instance Masitinib which is a tyrosine kinase inhibitor used as a veterinary medicine in the treatment of canine mast cell tumors. The firm is present in the United States and Europe. As of December 31, 2013, the Company operated though a subsidiary, AB Science USA LCC, based in the United States.

Company Info

AB SCIENCE SA

3, avenue George V

Paris ILE-DE-FRANCE FR

Employees: 45

AB Company Website

AB Investor Relations

Phone: 33147200014

AB SCIENCE SA / AB.PA FAQ

What is the stock price of AB SCIENCE SA today?

The current stock price of AB.PA is 1.154 EUR. The price decreased by -0.35% in the last trading session.


What is the ticker symbol for AB SCIENCE SA stock?

The exchange symbol of AB SCIENCE SA is AB and it is listed on the Euronext Paris - Matif exchange.


On which exchange is AB.PA stock listed?

AB.PA stock is listed on the Euronext Paris - Matif exchange.


What is the price forecast or stock price prediction for AB SCIENCE SA stock?

9 analysts have analysed AB.PA and the average price target is 3.53 EUR. This implies a price increase of 205.82% is expected in the next year compared to the current price of 1.154. Check the AB SCIENCE SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is AB SCIENCE SA worth?

AB SCIENCE SA (AB.PA) has a market capitalization of 68.51M EUR. This makes AB.PA a Micro Cap stock.


How many employees does AB SCIENCE SA have?

AB SCIENCE SA (AB.PA) currently has 45 employees.


What are the support and resistance levels for AB SCIENCE SA (AB.PA) stock?

AB SCIENCE SA (AB.PA) has a support level at 1.15 and a resistance level at 1.18. Check the full technical report for a detailed analysis of AB.PA support and resistance levels.


Is AB SCIENCE SA (AB.PA) expected to grow?

The Revenue of AB SCIENCE SA (AB.PA) is expected to grow by 10.94% in the next year. Check the estimates tab for more information on the AB.PA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy AB SCIENCE SA (AB.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does AB SCIENCE SA (AB.PA) stock pay dividends?

AB.PA does not pay a dividend.


When does AB SCIENCE SA (AB.PA) report earnings?

AB SCIENCE SA (AB.PA) will report earnings on 2025-09-29.


What is the Price/Earnings (PE) ratio of AB SCIENCE SA (AB.PA)?

AB SCIENCE SA (AB.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.15).


AB.PA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

AB.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to AB.PA. AB.PA has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AB.PA Financial Highlights

Over the last trailing twelve months AB.PA reported a non-GAAP Earnings per Share(EPS) of -0.15. The EPS increased by 40.17% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -33.79%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-94.41%
Sales Q2Q%-1.92%
EPS 1Y (TTM)40.17%
Revenue 1Y (TTM)10.52%

AB.PA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 87% to AB.PA. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of 7.32% and a revenue growth 10.94% for AB.PA


Ownership
Inst Owners0.14%
Ins Owners34.34%
Short Float %N/A
Short RatioN/A
Analysts
Analysts86.67
Price Target3.53 (205.89%)
EPS Next Y7.32%
Revenue Next Year10.94%